John D. Ulm

Array ( [id] => 7515514 [patent_doc_number] => 08039586 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-10-18 [patent_title] => 'Cerebral organic anion transporter and its gene' [patent_app_type] => utility [patent_app_number] => 09/787194 [patent_app_country] => US [patent_app_date] => 1999-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 7080 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039586.pdf [firstpage_image] =>[orig_patent_app_number] => 09787194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560817 [patent_doc_number] => 06437114 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Human dopamine receptor and uses' [patent_app_type] => B1 [patent_app_number] => 09/378074 [patent_app_country] => US [patent_app_date] => 1999-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 18172 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437114.pdf [firstpage_image] =>[orig_patent_app_number] => 09378074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7644059 [patent_doc_number] => 06428979 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Receptor protein for human B cell stimulatory factor-2' [patent_app_type] => B1 [patent_app_number] => 09/375417 [patent_app_country] => US [patent_app_date] => 1999-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 39 [patent_no_of_words] => 11355 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428979.pdf [firstpage_image] =>[orig_patent_app_number] => 09375417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533716 [patent_doc_number] => 06410691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Receptor protein for human B cell stimulatory factor-2' [patent_app_type] => B1 [patent_app_number] => 09/375416 [patent_app_country] => US [patent_app_date] => 1999-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 11345 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 554 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410691.pdf [firstpage_image] =>[orig_patent_app_number] => 09375416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641643 [patent_doc_number] => 07122342 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-17 [patent_title] => 'Protease-activated receptor PAR4 (ZCHEMR2)' [patent_app_type] => utility [patent_app_number] => 09/371333 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18949 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122342.pdf [firstpage_image] =>[orig_patent_app_number] => 09371333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839290 [patent_doc_number] => 20030036630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'NUCLEIC ACIDS ENCODING A G-PROTEIN COUPLED RECEPTOR INVOLVED IN SENSORY TRANSDUCTION' [patent_app_type] => new [patent_app_number] => 09/361652 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23612 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036630.pdf [firstpage_image] =>[orig_patent_app_number] => 09361652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5988005 [patent_doc_number] => 20020099199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'METHODS FOR TREATING COGNITIVE DISORDERS' [patent_app_type] => new [patent_app_number] => 09/350206 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 35596 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099199.pdf [firstpage_image] =>[orig_patent_app_number] => 09350206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1116536 [patent_doc_number] => 06800749 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-05 [patent_title] => 'G-protein coupled receptor' [patent_app_type] => B1 [patent_app_number] => 09/341016 [patent_app_country] => US [patent_app_date] => 1999-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7839 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800749.pdf [firstpage_image] =>[orig_patent_app_number] => 09341016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419553 [patent_doc_number] => 06225115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'DNA encoding taurine and GABA transporters and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/343361 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 61 [patent_no_of_words] => 46805 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225115.pdf [firstpage_image] =>[orig_patent_app_number] => 343361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1279865 [patent_doc_number] => 06646109 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit' [patent_app_type] => B1 [patent_app_number] => 09/345109 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 17787 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/646/06646109.pdf [firstpage_image] =>[orig_patent_app_number] => 09345109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1165534 [patent_doc_number] => 06759513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-06 [patent_title] => 'Death domain containing receptors' [patent_app_type] => B2 [patent_app_number] => 09/333966 [patent_app_country] => US [patent_app_date] => 1999-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 0 [patent_no_of_words] => 25152 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759513.pdf [firstpage_image] =>[orig_patent_app_number] => 09333966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316530 [patent_doc_number] => 06242572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Human G protein coupled lysophosphatidic acid receptor' [patent_app_type] => 1 [patent_app_number] => 9/325897 [patent_app_country] => US [patent_app_date] => 1999-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14386 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242572.pdf [firstpage_image] =>[orig_patent_app_number] => 325897 [rel_patent_id] =>[rel_patent_doc_number] =>)